LENZ Therapeutics (NASDAQ:LENZ) Major Shareholder Sells $9,134,778.24 in Stock
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) major shareholder Ra Capital Management, L.P. sold 2,718,684 shares of the company’s stock in a transaction dated Thursday, October 29th. The stock was sold at an average price of $3.36, for a total value of $9,134,778.24. Following the sale, the insider owned 57,559 shares of the company’s […]
3 Nov 00:09 · The Markets Daily